PlainRecalls
FDA Drug Moderate Class II Ongoing

Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01

Reported: May 7, 2025 Initiated: April 21, 2025 #D-0390-2025

Product Description

Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01

Reason for Recall

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Details

Recalling Firm
Eugia US LLC
Units Affected
N/A
Distribution
USA nationwide.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01. Recalled by Eugia US LLC. Units affected: N/A.
Why was this product recalled?
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 7, 2025. Severity: Moderate. Recall number: D-0390-2025.